117 related articles for article (PubMed ID: 15190989)
1. Modulation of inhibitor kappaB kinase/ nuclear factor kappaB signaling during critical illness: a double-edged sword.
Groesdonk HV; Senftleben U
Crit Care Med; 2004 May; 32(5):1239; author reply 1239-40. PubMed ID: 15190989
[No Abstract] [Full Text] [Related]
2. Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate.
Li X; Su J; Cui X; Li Y; Barochia A; Eichacker PQ
Expert Opin Investig Drugs; 2009 Aug; 18(8):1047-60. PubMed ID: 19555300
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-kappaB: is it a therapeutic target for the adjuvant treatment of sepsis?
Fink MP
Crit Care Med; 2003 Sep; 31(9):2400-2. PubMed ID: 14501975
[No Abstract] [Full Text] [Related]
4. Sesquiterpene lactone parthenolide, an inhibitor of IkappaB kinase complex and nuclear factor-kappaB, exerts beneficial effects in myocardial reperfusion injury. Shock 17(2):127-134, 2002.
Beranek JT
Shock; 2003 Feb; 19(2):191-2; author reply 192. PubMed ID: 12578131
[No Abstract] [Full Text] [Related]
5. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
Zingarelli B; Sheehan M; Hake PW; O'Connor M; Denenberg A; Cook JA
J Immunol; 2003 Dec; 171(12):6827-37. PubMed ID: 14662889
[TBL] [Abstract][Full Text] [Related]
6. Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates dextran sulfate sodium-induced colitis in mice.
Zhao ZJ; Xiang JY; Liu L; Huang XL; Gan HT
Int Immunopharmacol; 2012 Jan; 12(1):169-74. PubMed ID: 22155740
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-kappaB as a therapeutic target in critical care medicine.
Zingarelli B; Sheehan M; Wong HR
Crit Care Med; 2003 Jan; 31(1 Suppl):S105-11. PubMed ID: 12544984
[TBL] [Abstract][Full Text] [Related]
8. Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents.
Sheehan M; Wong HR; Hake PW; Malhotra V; O'Connor M; Zingarelli B
Mol Pharmacol; 2002 May; 61(5):953-63. PubMed ID: 11961112
[TBL] [Abstract][Full Text] [Related]
9. Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway.
Li XH; Xiao T; Yang JH; Qin Y; Gao JJ; Liu HJ; Zhou HG
Respir Res; 2018 Jun; 19(1):111. PubMed ID: 29871641
[TBL] [Abstract][Full Text] [Related]
10. The phosphoinositide-3 kinase survival signaling mechanism in sepsis.
Manukyan MC; Weil BR; Wang Y; Abarbanell AM; Herrmann JL; Poynter JA; Meldrum DR
Shock; 2010 Nov; 34(5):442-9. PubMed ID: 20386497
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target.
Chen W; Li Z; Bai L; Lin Y
Front Biosci (Landmark Ed); 2011 Jan; 16(3):1172-85. PubMed ID: 21196225
[TBL] [Abstract][Full Text] [Related]
12. Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury.
Ozawa Y; Kobori H
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F100-9. PubMed ID: 17409276
[TBL] [Abstract][Full Text] [Related]
13. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis.
Sheehan M; Wong HR; Hake PW; Zingarelli B
Crit Care Med; 2003 Sep; 31(9):2263-70. PubMed ID: 14501955
[TBL] [Abstract][Full Text] [Related]
14. Nardosinone-Type Sesquiterpenes from the Hexane Fraction of Nardostachys jatamansi Attenuate NF-κB and MAPK Signaling Pathways in Lipopolysaccharide-Stimulated BV2 Microglial Cells.
Ko W; Park JS; Kim KW; Kim J; Kim YC; Oh H
Inflammation; 2018 Aug; 41(4):1215-1228. PubMed ID: 29616391
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory resolution: new opportunities for drug discovery.
Gilroy DW; Lawrence T; Perretti M; Rossi AG
Nat Rev Drug Discov; 2004 May; 3(5):401-16. PubMed ID: 15136788
[No Abstract] [Full Text] [Related]
16. Parthenolide has limited effects on nuclear factor-kappa beta increases and worsens survival in lipopolysaccharide-challenged C57BL/6J mice.
Li X; Cui X; Li Y; Fitz Y; Hsu L; Eichacker PQ
Cytokine; 2006 Mar; 33(6):299-308. PubMed ID: 16720096
[TBL] [Abstract][Full Text] [Related]
17. A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.
Ziegelbauer K; Gantner F; Lukacs NW; Berlin A; Fuchikami K; Niki T; Sakai K; Inbe H; Takeshita K; Ishimori M; Komura H; Murata T; Lowinger T; Bacon KB
Br J Pharmacol; 2005 May; 145(2):178-92. PubMed ID: 15753951
[TBL] [Abstract][Full Text] [Related]
18. Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses.
Singer M; Jones AM
Crit Care; 2011 Jan; 15(1):203. PubMed ID: 21345278
[TBL] [Abstract][Full Text] [Related]
19. Cepharanthine exerts anti-inflammatory effects via NF-κB inhibition in a LPS-induced rat model of systemic inflammation.
Kudo K; Hagiwara S; Hasegawa A; Kusaka J; Koga H; Noguchi T
J Surg Res; 2011 Nov; 171(1):199-204. PubMed ID: 20334881
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental arthritis with self-assembling glycol-split heparin nanoparticles via inhibition of TLR4-NF-κB signaling.
Babazada H; Yamashita F; Hashida M
J Control Release; 2014 Nov; 194():295-300. PubMed ID: 25242730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
